Sanofi
FDA approves first short-acting, follow-on biologic of Lilly’s Humalog insulin product
December 12, 2017Manufacturing and Production, Sales and Marketing Admelog, FDA, Humalog, Sanofi, diabetes, insulin, pharma
The FDA has announced its approval of Sanofi’s Admelog (insulin lispro), the first follow-on biologic version of Eli Lilly’s Humalog …
Sanofi issues US-wide recall for arthritis product, after adverse events
December 12, 2017Manufacturing and Production Sanofi, Synvisc-One, biotech, drugs, pharma, pharmaceutical
Sanofi has announced a recall of 12,380 syringes of its Synvisc-One product for the treatment of osteoarthritis, after it was …
Philippines ups pressure on Sanofi over dengue vaccine
December 8, 2017Medical Communications Sanofi, biotech, drugs, pharma, pharmaceutical
Since Sanofi released further data from a six-year study which showed that the risk of a severe dengue reaction is …
Philippines to investigate “shameless public health scam”
December 4, 2017Sales and Marketing Sanofi, biotech, dengvaxia, drugs, pharma, pharmaceutical
The Philippines has announced that it will investigate how more than 730,000 children received a dengue vaccine, despite safety concerns …
Sanofi admits to dangers of its dengue vaccine
November 30, 2017Sales and Marketing Sanofi, biotech, dengue, drugs, pharma, pharmaceutical
After analysing six years’ worth of data on its dengue vaccine, Dengvaxia, Sanofi contacted health authorities to tell them that …
Sanofi signs $805 million deal for MS drug
November 10, 2017Medical Communications, Sales and Marketing Principia Biopharma, Sanofi, biotech, drugs, pharma, pharmaceutical
Sanofi has decided to build its pipeline in neurological disorders with the agreement to develop Principia Biopharma’s BTK inhibitor candidate …
Takeda’s dengue vaccine surpasses Sanofi’s in P2 trial
November 7, 2017Manufacturing and Production, Sales and Marketing Sanofi, Takeda, biotech, drugs, pharma, pharmaceutical
Sanofi spent more than $1.5 billion and two decades to develop the first ever vaccine for dengue fever, only a …
Sanofi Q3 results disappoint due to waning diabetes sales
November 2, 2017Sales and Marketing Lantus, Sanofi, diabetes, pharma
Sanofi readjusted its 2017 financial expectations after its third-quarter results came in lower than projected. The company revealed that net …
Pfizer to begin auction of consumer health division next month
October 26, 2017Sales and Marketing GSK, Pfizer, Proctor & Gamble, Sanofi, nestle
Following the recent revelation that Pfizer was considering the spin-out of its consumer health division, it has now emerged that …
Regeneron injects $100 million and 300 new roles into Irish production facility
October 26, 2017Manufacturing and Production Regeneron, Sanofi, manufacturing, pharma
Sanofi subsidiary Regeneron has announced its intention to expand its production plant in Limerick, Ireland – the largest scale bulk …
Sanofi launches patent infringement lawsuit against Mylan over diabetes pen
October 25, 2017Research and Development, Sales and Marketing Basaglar, Eli Lilly, Lantus, Mylan, Sanofi, diabetes, insulin, patent infringement, pharma
Sanofi has launched a lawsuit against Mylan as part of a dispute that alleges that the latter infringed upon 18 …
Peanut allergies? There’s a clinical trial looking to fix that
October 17, 2017Manufacturing and Production, Research and Development Aimmune, Regeneron, Sanofi, biotech, drugs, peanuts, pharma, pharmaceutical
Aimmune Therapeutics, a biotech company developing treatments for food allergies, announced that it has entered into a clinical trial collaboration …
Sanofi plans summit to tackle diabetes in 5 million Nigerian citizens
October 17, 2017Manufacturing and Production, Medical Communications Nigeria, Sanofi, WHO, diabetes, pharma
Sanofi Aventis Nigeria plans to put together a National Diabetes Summit to address crisis in the country as five million …
Sanofi set for €170 million expansion of vaccine facility
October 12, 2017Manufacturing and Production Sanofi, Sanofi Pasteur, biotech, drugs, influenza, pharma, pharmaceutical
Sanofi has announced that it plans to expand its vaccine manufacturing facility in Val de Reuil, France, with an injection …
Sanofi promotes global head of diabetes to expand role
October 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, biotech, diabetes, drugs, pharma, pharmaceutical
Sanofi has promoted Stefan Oelrich to the position of Executive Vice President of Diabetes and Cardiovascular (DCV), giving him a …
